Anxiety Levels in Adolescents Undergoing Endoscopy

Sponsor
Bursa Yüksek İhtisas Education and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04923490
Collaborator
(none)
180
1
13
13.8

Study Details

Study Description

Brief Summary

The aim of our study was to evaluate the pre-procedure state and trait anxiety levels of adolescents patients hospitalized for the purpose of gastrointestinal endoscopy performed under sedation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: state and trait anxiety scale levels

Detailed Description

Although anxiety is known to be a disorder that is much more relevant for adults, it is seen at a frequency of approximately 6.5% in the childhood and adolescence. Anxiety is usually examined in two different forms, state anxiety and trait anxiety. A total of 180 pediatric patients who underwent GIS endoscopy in our hospital were included in our study. Demographic data (age, gender, height, weight, educational status, school and grade), additional diseases and diagnoses were recorded. Our aim was to evaluate the anxiety and trait anxiety levels of adolescents scheduled for gastrointestinal system (GIS) endoscopy under sedation, after being admitted as a single-day inpatient and before the procedure. A form evaluating state and trait anxiety levels (Spielberger's state and trait anxiety scale) and another form consisting of demographic data were given to the patients. We requested that the forms be filled by the children themselves. After monitoring in the endoscopy unit, sedation was applied with IV anesthetic drugs routinely.Oxygenation was provided with nasal O2 in all patients. Heart rate (HR), mean arterial pressure (MAP) and oxygen saturation (SpO2) were monitored. Also complications (bradycardia, tachycardia, arrhythmia, hypotension, hypertension, bronchospasm, decrease in SpO2, apnea) were recorded.

Study Design

Study Type:
Observational
Actual Enrollment :
180 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Evaluation of State and Trait Anxiety Levels in Adolescents Undergoing Endoscopy Under Anesthesia
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Mar 1, 2020
Actual Study Completion Date :
Jul 1, 2020

Outcome Measures

Primary Outcome Measures

  1. anxiety level [before anesthesia induction]

    Score between 0-19: No anxiety Score between 20-39: Mild anxiety Score between 40-59: Moderate anxiety Score between 60-79: Severe anxiety 80 and above score: Panic level anxiety

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Children aged 11-18 years

  • ASA I-II

  • cooperative

  • literate

  • undergoing elective endoscopic procedures

Exclusion Criteria:
  • under 11 years of age

  • uncooperative

  • illiterate

  • had known psychiatric disorders or were using psychiatric drugs

  • emergency endoscopy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bursa YIERH Bursa Turkey 16000

Sponsors and Collaborators

  • Bursa Yüksek İhtisas Education and Research Hospital

Investigators

  • Principal Investigator: Ümran Ü Karaca, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Derya D Karasu, Assoc Prof, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Şermin Ş Eminoğlu, MD, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Şeyda Efsun ŞE Özgünay, Assoc Prof, Bursa Yüksek İhtisas Education and Research Hospital
  • Study Chair: Tuğba T Onur, MD, Bursa Yüksek İhtisas Education and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Umran Karaca, Principal investigator, Bursa Yüksek İhtisas Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT04923490
Other Study ID Numbers:
  • bursa hospital
First Posted:
Jun 11, 2021
Last Update Posted:
Jun 11, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Umran Karaca, Principal investigator, Bursa Yüksek İhtisas Education and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 11, 2021